Elucida Oncology Submits IND Application for ELU-001 for the Treatment of Cancers Overexpressing Folate-Receptor Alpha
19. Juli 2021 10:00 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., July 19, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that it has submitted an...
Elucida Oncology Announces Three Key Additions to Its Board of Directors and the Appointment of Robert Essner as Chairman of the Board
29. April 2021 11:00 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., April 29, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today three key additions to...
Elucida Oncology to Present Preclinical Data on ELU001 at the American Association for Cancer Research Annual Meeting
29. März 2021 10:15 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., March 29, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today that an abstract...
Elucida Oncology Closes $44 Million Series A-1 Financing
12. Januar 2021 09:15 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today it has closed a $44...
Elucida Oncology to Present at the 39th Annual J.P. Morgan Healthcare Conference
07. Januar 2021 14:00 ET
|
Elucida Oncology, Inc
Elucida will also participate in the BIO Partnering @ JPM event MONMOUTH JUNCTION, N.J., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in...
Elucida Oncology Appoints Dr. Eliel Bayever as Chief Medical Officer
01. Oktober 2020 15:32 ET
|
Elucida Oncology, Inc
MONMOUTH JUNCTION, N.J., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Elucida Oncology, a biotechnology company pioneering the next frontier in targeted cancer therapy, announced today the appointment of Dr....